Wockhardt to launch generic BP drug

Singapore: Wockhardt received final approval from the US FDA for marketing extended-release tablets containing 2.5mg, 5m...

August 22, 2012 | Wednesday | Regulatory
GE Healthcare, Fortis pioneer Asia's first eICU

New Delhi: Fortis Healthcare and GE Healthcare have launched Asia's first electronic intensive care unit (eICU) facility...

July 9, 2012 | Monday | News
Biologics: Indian companies address quality issues

In recent years, licensing and quality control for manufacturers and national regulatory authorities has become more com...

March 7, 2012 | Wednesday | News
Dept of health, biotech sign MoU for affordable health

New Delhi: Dr V M Katoch, secretary, Department of Health Research (DHR), and Dr M K Bhan, secretary, Department of Biot...

October 4, 2012 | Thursday | News
Sanofi to supply 1.7 bn polio vaccines to GPEI

Bangalore: Sanofi Pasteur, the vaccines division of Sanofi, will provide 1.7 billion doses of oral polio vaccine (OPV) t...

April 26, 2013 | Friday | News
India suffers adverse effects of clinical research

Everything does not seem to be well in the pharmaceutical industry of Asia's third largest economy - India. Although the...

August 29, 2013 | Thursday | Analysis
Take gets Oracle PartnerNetwork specialized status

Chennai: Take Solutions, a leader in the supply chain management (SCM) and life sciences domains and a Gold level membe...

November 28, 2012 | Wednesday | News
APAC's NSCLC market to show robust growth by 2019

Singapore: The GBI Research has revealed that the non-small cell lung cancer (NSCLC) therapeutics market value in the As...

March 21, 2014 | Friday | News
Urbanization causes elderly health suffering in India

Bangalore: A report titled, 'Preventive Care and Healthy Ageing Global Perspective', released by the the Economist Intel...

September 28, 2012 | Friday | News
Agilent India head: Declining Rupee has hit imports

Agilent Technologies has come a long way since its inception in a garage at Palo Alto in California, US. A company that ...

February 1, 2013 | Friday | Influencers
Novartis hits out at India's IPR environment

New Delhi: After losing a patent case for its cancer drug Glivec, drug maker Novartis has lashed out at India's way of d...

August 19, 2013 | Monday | News
Which domain of clinical research do APAC CROs focus on?

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...

September 18, 2013 | Wednesday | Analysis
TAKE Solutions announces Q4 results

Bangalore: TAKE Solutions, a leader in the supply chain management (SCM) in the life sciences (LS) domain, announced its...

May 28, 2012 | Monday | Company results
Wockhardt gets FDA nod for generic treatment of enlarged prostate

Mumbai: Pharmaceutical and biotechnology major Wockhardt has received final approval from the US Food & Drug Adminis...

August 15, 2012 | Wednesday | News
Imagenex on mission against osteoporosis

India is one of the largest affected countries in the world suffering from osteoporosis. This is evident from the fact t...

March 16, 2012 | Friday | News
Wockhardt gets FDA nod for epilepsy generic

Mumbai: Pharmaceutical and biotechnology major, Wockhardt, has received final approval from the US FDA for marketing 25...

January 9, 2013 | Wednesday | News
Ranbaxy's fall from grace

Not long ago, it was one of India's iconic companies. Ranbaxy, which is now a subsidiary of Japanese giant Daiichi Sanky...

May 29, 2013 | Wednesday | Opinion
GVK, Onconova to develop cancer drugs

Singapore: GVK Bio and US-based Onconova Therapeutics entered into a novel joint partnership to develop new drugs for c...

January 10, 2013 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls